methylprednisolone hemisuccinate and Dysarthosis

methylprednisolone hemisuccinate has been researched along with Dysarthosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gold, R; Hoepner, R; Krogias, C; Müller, A; Schneider-Gold, C; Schröder, A	1

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Dysarthosis

Article	Year
Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab. JAMA neurology, 2013, Volume: 70, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Chorea; Combined Modality Therapy; Dysarthria; Dystonia; Epilepsy; Follow-Up Studies; Humans; Male; Membrane Proteins; Methylprednisolone Hemisuccinate; Middle Aged; Nerve Tissue Proteins; Receptors, Interleukin-6; Remission Induction; Syndrome; Treatment Outcome	2013

Article

Year

Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab.

JAMA neurology, 2013, Volume: 70, Issue:8

Topics: Antibodies, Monoclonal, Humanized; Chorea; Combined Modality Therapy; Dysarthria; Dystonia; Epilepsy; Follow-Up Studies; Humans; Male; Membrane Proteins; Methylprednisolone Hemisuccinate; Middle Aged; Nerve Tissue Proteins; Receptors, Interleukin-6; Remission Induction; Syndrome; Treatment Outcome

2013